Rendez-vous of the bio-pharmaceutical industry - Québec City, October 6 and 7
- A new challenge: Develop new drugs, more focused and combined with
customised healthcare

QUEBEC, Sept. 27 /CNW Telbec/ - As of January 1^st, 2011, the baby-boomers will be dramatically represented in Quebec. In fact, more than 15,000 persons will reach retirement age every month. Parallel to this phenomenon, the healthcare industry is undergoing changes: the arrival of new information networks and rapid access to ICT/health information, of new diagnostic products to analyse the specific biological profile of a patient, of new medications that directly target molecules that are "responsible for the disease", are as many innovations that will transform today's "symptom analysis" medicine into the "more preventive and specific to the molecular profile of a group of persons" medicine  of tomorrow, mentioned Mr. Martin Godbout, president of BioContact Québec.

Over the course of the next few days, the BioContact Québec symposium held at the Château Frontenac will welcome more than a hundred biopharmaceutical companies gathered collectively under such disciplines as cancer, cardiology, endocrinology/metabolism, genomics/proteomics, neurobiology, immunology/infectiology, as well as the medical technologies. This exchange meeting surrounding "biopharmaceutical partnership" is a structured approach of personalised meetings between biopharmaceutical and pharmaceutical companies, universities, consulting firms, venture capital companies and government representatives.

This year, the 17^th edition of BioContact Québec will give rise to an in-depth reflection on the new ways of doing things, both in medical research and in the development of medications and implementation of new partnership agreements. "In a world where economic stakes are high, where the parties involved are to face a reduction in the costs associated to the development of new drugs and health care in general, in a world where ethics, information management and constant arrival of new technologies will overcome the entire floor in the course of the next decades, there is no doubt that discussions will be of utmost interest during this 17^th edition of BioContact Québec", concluded Martin Godbout.

We therefore invite you to join the 600 participants in this annual meeting of the biopharmaceutical industry.

Media accreditation required
To participate in the 17^th edition of BioContact Québec 2010 in the quality of MEDIA, journalists must submit their accreditation form to the following address: [email protected]. Please note that the event's complete program is available at www.biocontact.ca

We are also available for interviews. To make an appointment, please contact us at the number below.

For further information:

Hélène Turcotte, Pressroom Co-ordinator
BioContact Québec 2010
Telephone: [phone]
[email protected]